MetLife Investment Management’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$286K	Sell	53,779 -602	-1%	-$3.2K	﹤0.01%	1987
2025 Q1	$482K	Sell	54,381 -550	-1%	-$4.88K	﹤0.01%	1746
2024 Q4	$753K	Buy	54,931 +3,231	+6%	+$44.3K	﹤0.01%	1568
2024 Q3	$1.42M	Hold	51,700	–	–	0.01%	1199
2024 Q2	$1.26M	Buy	51,700 +7,693	+17%	+$188K	0.01%	1225
2024 Q1	$938K	Buy	44,007 +1,338	+3%	+$28.5K	0.01%	1333
2023 Q4	$817K	Hold	42,669	–	–	0.01%	1418
2023 Q3	$684K	Hold	42,669	–	–	0.01%	1445
2023 Q2	$989K	Hold	42,669	–	–	0.01%	1277
2023 Q1	$991K	Hold	42,669	–	–	0.01%	1227
2022 Q4	$619K	Hold	42,669	–	–	﹤0.01%	1504
2022 Q3	$814K	Hold	42,669	–	–	0.01%	1297
2022 Q2	$775K	Hold	42,669	–	–	0.01%	1355
2022 Q1	$1.08M	Buy	42,669 +15,255	+56%	+$384K	0.01%	1285
2021 Q4	$757K	Hold	27,414	–	–	0.01%	1261
2021 Q3	$885K	Hold	27,414	–	–	0.01%	1186
2021 Q2	$838K	Hold	27,414	–	–	0.01%	1270
2021 Q1	$835K	Sell	27,414 -4,400	-14%	-$134K	0.01%	1247
2020 Q4	$629K	Hold	31,814	–	–	0.01%	1364
2020 Q3	$415K	Hold	31,814	–	–	﹤0.01%	1465
2020 Q2	$361K	Hold	31,814	–	–	﹤0.01%	1556
2020 Q1	$455K	Hold	31,814	–	–	0.01%	1266
2019 Q4	$866K	Hold	31,814	–	–	0.01%	1163
2019 Q3	$911K	Hold	31,814	–	–	0.01%	1117
2019 Q2	$884K	Buy	31,814 +2,051	+7%	+$57K	0.01%	1165
2019 Q1	$988K	Hold	29,763	–	–	0.01%	1091
2018 Q4	$865K	Hold	29,763	–	–	0.01%	1083
2018 Q3	$1.37M	Hold	29,763	–	–	0.01%	1000
2018 Q2	$1.11M	Hold	29,763	–	–	0.01%	978
2018 Q1	$879K	Hold	29,763	–	–	0.01%	1060
2017 Q4	$1.02M	Buy	+29,763	New	+$1.02M	0.01%	1025